Peter WT Pisters, M.D., begins tenure as MD Anderson president
MD Anderson Cancer Center welcomes Peter WT Pisters, M.D., as the 76-year-old institution’s fifth full-time president. Pisters was...
Six MD Anderson researchers chosen for AAAS
In recognition of their contributions to basic, translational, and clinical research, six faculty members from MD Anderson Cancer...
Chronic stress may promote resistance to lung cancer therapy
Elevated levels of chronic stress hormones, such as those produced by psychological distress, may promote resistance to drugs commonly...
Addition of ribociclib improves survival...
The addition of ribociclib, an inhibitor of the cell cycle, to standard hormone therapy significantly improved progression-free survival (PFS) in pre-menopausal patients with advanced hormone receptor-positive (HR+) breast cancer, according to results of the MONALEESA-7 Phase III clinical trial led by researchers at MD Anderson.
The trial results, presented at the 2017 San Antonio Breast Cancer Symposium by...
Study shows PARP inhibitor’s benefit for advanced breast...
In a randomized, Phase III trial led by MD Anderson researchers, the PARP inhibitor talazoparib extended progression-free survival...
Advances in blood cancer treatment presented at ASH meeting
Researchers from MD Anderson Cancer Center presented their latest findings involving drug treatments for blood cancers at the...
Repurposed drug yields unprecedented response rates in...
A targeted therapy resurrected by the Moon Shots Program™ at MD Anderson has produced unprecedented response rates among patients with...
MD Anderson named site of NIH immunotherapy research center
A major national effort to expand the reach of cancer immunotherapy in order to benefit more patients will draw upon the expertise...
'I’ve seen suffering and dying from an avoidable disease'
In Texas, the number is even lower. Only 33% of Texas teens were up to date. That’s a lot of room for improvement.
Having spent the...
MD Anderson pancreatic cancer researcher to lead Dream Team
Deeply entrenched and mature by the time it’s found, pancreatic cancer is one of the hardest types of the disease to defeat. A Dream...
5 years in, Moon Shots Program is primed for continued...
It's been five years since MD Anderson launched its Moon Shots Program™, a collaborative effort to more quickly turn scientific...
Hydrocodone prescriptions decreasing, study shows
The effectiveness of opioids in treating cancer pain has been well established over the years. But today’s opioid epidemic that began...
Pioneering breast cancer researcher V. Craig Jordan elected...
V. Craig Jordan, Ph.D., professor of Breast Medical Oncology, has been elected to the National Academy of Medicine for his discovery...
Healthy eating and exercise habits may heighten...
Pediatric cancer patients who eat a healthy diet and exercise regularly may experience fewer cancer treatment side effects later in...
Multiple surgeries may be unnecessary for some stage zero...
Patients with stage zero breast cancer, also known as ductal carcinoma in situ, who undergo breast-conserving surgery that results in...
New therapies for follicular lymphoma on the horizon
Recently approved targeted and immunotherapy drugs are helping patients diagnosed with follicular lymphoma live longer. Knowing the...
For carriers of Lynch syndrome, an elevated cancer risk...
When Craig Bunk began experiencing severe abdominal pain, blood loss and fatigue, his family doctor thought a stomach ulcer was to...
Research training programs to address cancer disparities among...
Cancer is the second leading cause of death in the U.S., and will claim the lives of an estimated 600,920 in this country in 2017,...
Tibetan yoga may help breast cancer patients sleep better
Practicing Tibetan yoga twice a week may reduce sleep disturbances and improve sleep quality for breast cancer patients receiving...
Researchers analyze precursor lesions to define earliest...
Despite significant advances in lung cancer treatment, new approaches for early detection and prevention remain limited because the...
How to handle side effects of CAR-T cell therapy
Immune-cell based therapies opening a new frontier for cancer treatment carry unique, potentially lethal side effects that provide a...
Building on progress against pancreatic cancer
Nationally, only about 9% of people diagnosed with pancreatic cancer survive five years. In most cases, the disease has spread to...
Immunotherapy is unleashed on blood cancers
Tomas Sandoval was about to become a father for the second time in June 2014, when he was devastated to learn he had non-Hodgkin...
In the news: Hero doctors braved Harvey to reach patients
Hurricane Harvey brought with it unprecedented rainfall – 27 trillion gallons – and staggering destruction – 33 Texas counties...
Sunbeatables' lessons in skin cancer prevention now...
As teachers across the country prepare for a new school year, it is now easier than ever to make sun safety a part of daily lesson...
Study helps predict lung cancer patients’ response to checkpoint...
An MD Anderson study may help researchers predict which patients with non-small cell lung cancer will respond to checkpoint blockade...
Tumor-targeting drug shows potential for treating bone...
The treatment of osteosarcoma, the most common tumor of bone, is challenging. An MD Anderson study found a drug known as bone...
Findings may help doctors ‘customize’ glioblastoma treatment
Patterns in how genes express themselves may help doctors personalize treatment for glioblastoma, the most deadly of brain cancers,...
Identifying an enzyme that keeps ovarian cancer safe from...
A study of high-grade ovarian cancer has shown the enzyme protein kinase C iota (PRKCI) to be an ovarian oncogene, suggesting PRKCI...
Symposium to address prevention, detection and treatment of...
This fall, experts from MD Anderson, the American Dental Association (ADA), the Centers for Disease Control and Prevention and the...
MD Anderson is again No. 1 in cancer care
MD Anderson Cancer Center again has been ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best Hospitals” survey...
Together, chemo and proton therapy lengthen survival for...
For patients with advanced, inoperable stage 3 lung cancer, chemotherapy and a specialized form of radiation treatment known...
MD Anderson is first in Texas to be accredited to train...
Since 2006, MD Anderson’s Tobacco Treatment Program (TTP) has been providing tobacco cessation services to patients and employees...
Metastatic colorectal cancer patients with a certain...
A practice-changing clinical trial conceived and led by MD Anderson investigators showed that metastatic colorectal cancer patients...
Engineered exosomes shut down pancreatic tumor growth in...
Genetic manipulation of exosomes, virus-sized particles released by all cells, may offer a new therapeutic approach to treating...
Biomarkers predict response to breast cancer treatment
Two challenges in treating patients with estrogen-positive breast cancer (ER+) have been the inability to predict who will respond to...
Two combination therapies shrink melanoma brain metastases...
High response rates to a pair of combination therapies point to potentially new options for a group of metastatic melanoma patients...
Targeting a genetic mutation that causes many cancers
A study at MD Anderson Cancer Center has shown promise for effective treatment of therapy-resistant cancers caused by a mutation...
A diverse gut bacteria may slow metastatic melanoma
Researchers at MD Anderson Cancer Center have found that the blend of bacteria in the digestive tract of metastatic melanoma patients...
Utilizing the body’s natural born killers to take out blood...
Natural killer cells sound menacing, but they play a friendly role in keeping us healthy. And they might do much more in stopping...
Treatment puts the freeze on breast cancer
When Jo Ann West learned she had early-stage breast cancer, her doctor suggested an inventive new treatment that involves no major...
Drug shows promise in treating BRCA-related breast cancer
After all 13 breast cancer patients in a first-of-its-kind clinical trial responded positively to a new targeted therapy, MD Anderson...
Research shows HPV vaccine’s enormous potential to stop...
Researchers have found that the human papillomavirus (HPV) vaccine may reduce the rate of oral HPV infections in young adults by as...
A first-line therapy’s success in treating rare mantle cell...
Two new clinical trials at MD Anderson are taking aim at mantle cell lymphoma – a rare form of non-Hodgkin’s lymphoma.
Most mantle...
Leukemia doctor creates a clinical trial for patients ineligible...
What if you or a loved one had cancer but were denied access to a research study testing a poten-tially beneficial treatment?
This...
Is this enzyme the key to the formation of highly malignant brain...
There are many moving parts when it comes to the mechanics of how otherwise healthy cells are transformed into those that cause deadly...
Program helps at-risk group beat nicotine addiction
More than 50 years after the U.S. Surgeon General first warned about the dangers of cigarettes, smoking rates have plummeted.
An MD Anderson drug developed to starve cancer is tested on...
For decades, combination chemotherapy has been the main treatment for patients with acute myeloid leukemia (AML) – an aggressive...
Grants nurture innovative approaches to pancreatic cancer...
New initiatives to improve the treatment of pancreatic cancer have earned two early-career investigators at MD Anderson multi-year...
Immunotherapy pioneer named one of TIME's most influential...
MD Anderson Chair of Immunology Jim Allison, Ph.D., whose pivotal work to attack cancer by treating the immune system instead of...
A new approach: Partnering with dentists to prevent oral cancer
The American Dental Association (ADA) and MD Anderson Cancer Center have announced a joint effort to improve patient outcomes...
Andrew Sabin Family Fellows awarded $100,000 in research funding
Eight MD Anderson researchers have been named 2017 Andrew Sabin Family Fellows. The Andrew Sabin Family Fellowship Program provides...
MD Anderson genetics expert elected to National Academy of...
Guillermina Lozano, Ph.D., chair of Genetics at MD Anderson, is one of 84 new members and 21 foreign associates elected to the...
Dual procedures offer relief from lymphedema
Cancer patients who have undergone lymph node removal or radiation therapy as part of cancer treatment know all too well the pain and...
Breast cancer patients who respond to chemo may not need...
Select breast cancer patients who after undergoing chemotherapy as their first line of treatment show no residual cancer – a state...
MD Anderson cancer experts share discoveries at AACR Annual...
A number of MD Anderson physicians and scientists chaired or co-chaired sessions and presented research, ranging from racial...
Evidence supports the need to raise the legal tobacco age
(Editor's note: This article was updated on April 9, 2019 to reflect new Texas legislation filed in 2019, similar legislation passed...
Neurofeedback reduces chemo-induced nerve damage
A type of functional brain training known as neurofeedback shows promise in reducing symptoms of chemotherapy-induced nerve damage, or...
Breakthrough research targets immunotherapy resistance
Stories of immunotherapy’s success against metastatic melanoma in patients such as former President Jimmy Carter are well publicized,...
Drug outperforms chemo for treatment of acute lymphoblastic...
The biopharmaceutical drug blinatumomab is more effective for the treatment of relapsed or treatment-resistant acute lymphoblastic...
Advanced radiation technique shows promise for lung cancer...
An advanced form of image-guided radiation therapy known as intensity modulated proton therapy (IMPT) has shown early promise for the...
MD Anderson scientists unraveling complexities of bile duct cancer
Extensive genomic analysis led by MD Anderson researchers has opened new avenues to explore in the treatment of a rare and tenaciously...
Immunotherapy pioneer Jim Allison honored with Sjöberg,...
International recognition continues to accumulate for Jim Allison, Ph.D., for opening up an entirely new way to treat cancer by...
Can gut bacteria affect cancer’s response to immunotherapy?
Melanoma patients’ response to a major form of immunotherapy is associated with the diversity and makeup of trillions of potential...
Loss of tumor suppressor allows triple-negative breast...
When triple-negative breast cancer is still in its earliest, pre-cancerous stages, the tumor suppressor miRNA-29c becomes...
Scientists identify aggressive pancreatic cancer cells and...
Researchers have identified a gatekeeper protein that prevents pancreatic cancer cells from transitioning into a particularly...
Chemotherapy may not be necessary for early-stage breast...
A new study from MD Anderson finds that women with early-stage breast cancer who had an intermediate risk recurrence score (RS)...
Trio of biomarkers could boost early detection of...
Adding two blood-borne proteins associated with cancer cell migration increases the predictive ability of the current biomarker for...
A new way to kill lung cancer with little collateral damage
Next-generation cyclin dependent kinase 2/9 (CDK2/9) inhibitors offer a new way to kill lung cancer while doing minimal harm to normal...
Gene may promote formation of breast, prostate tumors
UBE20, a gene found on chromosome 17, may play a role in breast and prostate tumor formation, MD Anderson researchers found in a...
Hormone therapy shows big promise for ovarian cancer...
For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma (LGSC), hormone...
Staining technique predicts breast cancer recurrence
Cyclin E, a protein important for DNA replication, is present in various forms of cancer in high levels. Overexpression of cyclin E...
Mobile devices help motivate cancer survivors to exercise,...
Researchers in MD Anderson’s Center for Energy Balance in Cancer Prevention and Survivorship are using mobile technology to learn what...
ECHO 'Superhub' status expands MD Anderson's reach into...
Major innovations in cancer prevention, screening and treatment continue to develop at a rapid pace, especially through research...
'Collateral lethality' may lead to new cancer treatments
Cancer cells often delete genes that normally suppress tumor formation. These deletions also may extend to neighboring genes, an event...
Study links contralateral breast cancer with dense tissue
Breast cancer patients with dense breast tissue have almost a two-fold increased risk of developing disease in the other breast,...
Partnership formed to speed up widespread use of liquid...
MD Anderson Cancer Center and Guardant Health recently announced a multi-year partnership designed to more quickly make comprehensive...
Cancer centers join together to endorse new HPV vaccine...
As national vaccination rates for the human papillomavirus (HPV) remain low, MD Anderson Cancer Center has again united with the...
FDA’s push to regulate smokeless tobacco should be applauded
MD Anderson Cancer Center fully supports the proposed rule by the Food and Drug Administration (FDA) to limit a known carcinogen in...
FDA approves immunotherapy drug for advanced bladder cancer
Bladder cancer patients with advanced disease have a new option for treatment after the Food and Drug Administration (FDA) this week...
Global cancer prevention efforts support World Cancer Day...
World Cancer Day is Saturday, Feb. 4. It’s the one singular initiative under which the entire world unites to fight cancer through...
Some breast cancer patients may avoid surgery in future
In a pilot study conducted at MD Anderson Cancer Center, image-guided biopsies identified select breast cancer patients who achieved...
First-of-its-kind study examines cosmetic outcomes for...
In the first study evaluating patient-reported cosmetic outcomes in older women with breast cancer, MD Anderson researchers found...
Nivolumab plus chemotherapy improves leukemia patients’...
The immunotherapy drug nivolumab in combination with standard chemotherapy more than doubled response rates and improved overall...
New partnerships push innovative approaches to cancer...
In the modern world of biomedical research, collaborations between academic institutions and pharmaceutical and biotech companies have...
Quality of life’s role in improving exercise study...
Certain quality-of-life factors, such as pain and anxiety, have a significant impact on the likelihood of endometrial cancer survivors...
Discovery may lead to earlier treatment of...
A study by MD Anderson researchers is shedding new light on how the protein PD-L1 suppresses the immune system, which may help...